Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.

ABSTRACT:

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC7832443 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature